A Christmas present for Nordic life science! VC fund, Hadean Ventures, is ready to inject €100M into particularly Nordic Biotech
After closing its first fund, Hadean Ventures, the new €100M VC fund based in Oslo, is ready to inject €100M into Nordic Biotech, according to a story published in Europe´s leading online biotech media, German-based Labiotech.eu
“The Nordic region has outstanding scientists, a stable, business-friendly environment, and a vibrant start-up community, yet very few life science specialist venture funds are on the ground. We see an exceptionally strong deal flow of high potential opportunities here.” says Ingrid Teigland Akay, Managing Partner of Hadean, commenting on the gap in the market that the VC hopes to fill.
Read full article here.